PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

Chart, page-3441

  1. 4,381 Posts.
    lightbulb Created with Sketch. 6924
    What gives you the impression that we are no closer to a partnership?

    However, every month that goes by without a partnership deal being announced isn't necessarily a bad thing at this stage. Getting a partnership deal before real empirical data on a DMOAD study could be a terrible result for the medium to longer term sh. I give you one billion USD 3 years ago or possibly 5 Billion next year (spec statement, only example, not actual figures, illustrative only etc blah)

    I'm a long term holder...I would rather wait just a few more weeks (literally) and observe what's happening within the synovial joint....its potentially a different-better set of data altogether compared to the 2 month read out; we could have further separation between the cohorts, it could be meaningful. We haven't had any real data in structural objective sightings in the joint cavity in such a human study. We could get a REAL taste of this imminently.

    Mate I don't know about you but this is worth waiting for.

    Let me clean up my backyard, let me spend a few more weeks watering the garden, removing the weeds, its boring, its tedious but isn't it so darned lucrative...tending to the roses just before I put my house on auction. Painful yes, frustrating sure...but it could just be one of the best results ever. I'm not an excessively betting man, but this one is worth the wait.



    My thoughts

    Last edited by Mozzarc: 24/02/23
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.